| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 11 Jun 24 | ENTO Entero Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 24,889 | 0.00 | 24,889 |
| 13 Mar 24 | ENTO Entero Therapeutics | Common Stock, par value $0.0001 per share | Grant | Acquire A | Yes | No | 0 | 440 | 0.00 | 440 |
| 13 Mar 24 | ENTO Entero Therapeutics | Stock Option Common Stock, par value $0.0001 per share | Grant | Acquire A | No | No | 0.81 | 52,980 | 42.91 k | 52,980 |
| 13 Mar 24 | ENTO Entero Therapeutics | Series G Non-Voting Convertible Preferred Stock Common Stock, par value $0.0001 per share | Grant | Acquire A | Yes | No | 0 | 140.7 | 0.00 | 140.7 |
